{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:49:05Z","timestamp":1783406945470,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>DICER1<\/jats:italic>-associated central nervous system sarcoma (DCS) without evidence of other cancer-related syndromes is rare. Though the morphology of DCS was highly variable, the immunophenotype was predominant myogenic phenotype. Other lineage markers were consistently negative.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a case of DCS with neurogenic differentiation proved by immunohistochemical staining and whole-exome sequencing (WES). An 8-year-old female patient presented with 8-day history of headache, nausea and vomiting. Magnetic resonance imaging (MRI) revealed a heterogeneous mass in the left parietal lobe. The patient underwent the craniotomy via left parietal approach to resect the tumor completely. Histologically, the tumor predominately showed fibrosarcoma-like spindle cells with obvious cytoplasmic eosinophilic globules. Immunohistochemically, the tumor stained positively for DICER1, Desmin, and several neurogenic markers. <jats:italic>DICER1<\/jats:italic> somatic hotspot mutation was confirmed by WES, as well as <jats:italic>TP53<\/jats:italic> and <jats:italic>RAF1<\/jats:italic> mutations which were commonly found in DCS, and other sarcoma-associated genes including <jats:italic>AR<\/jats:italic>, <jats:italic>AXL<\/jats:italic> and <jats:italic>ETV5<\/jats:italic> mutations. Subsequently, the result of Gene Ontology (GO) analysis showed that the mutated genes in this case were involved in neuron development. All of these findings indicated the diagnosis of DCS with neurogenic differentiation. Postoperatively, the patient received high-dose radiotherapy (60\u00a0Gy) and chemotherapy. There was no MRI evidence of tumor recurrence at the 21-month postoperative follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This unusual DCS case with neuronal differentiation is an important addition to the immuno-phenotypic spectrum of DCS. Although the prognosis for DCS is poor, gross tumor resection with high dose radiotherapy and chemotherapy may assist in prolonging survival.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-022-01252-1","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:03:04Z","timestamp":1664013784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Kun","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5787-4951","authenticated-orcid":false,"given":"Xueling","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"issue":"12","key":"1252_CR1","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.ejso.2019.08.015","volume":"45","author":"G Zhang","year":"2019","unstructured":"Zhang G, Xiao B, Huang H, Zhang Y, Zhang X, Zhang J, et al. Intracranial synovial sarcoma: a clinical, radiological and pathological study of 16 cases. Eur J Surg Oncol. 2019;45(12):2379\u201385. https:\/\/doi.org\/10.1016\/j.ejso.2019.08.015.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"1252_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00431-015-2565-x","volume":"174","author":"M Kuhlen","year":"2015","unstructured":"Kuhlen M, Borkhardt A. Cancer susceptibility syndromes in children in the area of broad clinical use of massive parallel sequencing. Eur J Pediatr. 2015;174(8):987\u201397. https:\/\/doi.org\/10.1007\/s00431-015-2565-x.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"1252_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrclinonc.2014.41","volume":"11","author":"KA McBride","year":"2014","unstructured":"McBride KA, Ballinger ML, Killick E, Kirk J, Tattersall MH, Eeles RA, et al. Li-Fraumeni syndrome: cancer risk assessment and clinical management. Nat Rev Clin Oncol. 2014;11(5):260\u201371. https:\/\/doi.org\/10.1038\/nrclinonc.2014.41.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1252_CR4","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ajmg.a.38142","volume":"173","author":"T Ripperger","year":"2017","unstructured":"Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017\u201337. https:\/\/doi.org\/10.1002\/ajmg.a.38142.","journal-title":"Am J Med Genet A"},{"issue":"10","key":"1252_CR5","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz KAP, Williams GM, Kamihara J, Stewart DR, Harris AK, Bauer AJ, et al. DICER1 and associated conditions: identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res. 2018;24(10):2251\u201361. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3089.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1252_CR6","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1002\/mgg3.555","volume":"7","author":"J Kim","year":"2019","unstructured":"Kim J, Schultz KAP, Hill DA, Stewart DR. The prevalence of germline DICER1 pathogenic variation in cancer populations. Mol Genet Genomic Med. 2019;7(3):e555. https:\/\/doi.org\/10.1002\/mgg3.555.","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"1252_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-018-1871-6","volume":"136","author":"C Koelsche","year":"2018","unstructured":"Koelsche C, Mynarek M, Schrimpf D, Bertero L, Serrano J, Sahm F, et al. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Acta Neuropathol. 2018;136(2):327\u201337. https:\/\/doi.org\/10.1007\/s00401-018-1871-6.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1252_CR8","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41379-020-0516-1","volume":"33","author":"J Kamihara","year":"2020","unstructured":"Kamihara J, Paulson V, Breen MA, Laetsch TW, Rakheja D, Shulman DS, et al. DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor. Mod Pathol. 2020;33(10):1910\u201321. https:\/\/doi.org\/10.1038\/s41379-020-0516-1.","journal-title":"Mod Pathol"},{"issue":"4","key":"1252_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-019-01997-y","volume":"139","author":"L de Kock","year":"2020","unstructured":"de Kock L, Priest JR, Foulkes WD, Alexandrescu S. An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol. 2020;139(4):689\u2013701. https:\/\/doi.org\/10.1007\/s00401-019-01997-y.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1252_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/his.14217","volume":"78","author":"S Alexandrescu","year":"2021","unstructured":"Alexandrescu S, Meredith DM, Lidov HG, Alaggio R, Novello M, Ligon KL, et al. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant. Histopathology. 2021;78(2):265\u201375. https:\/\/doi.org\/10.1111\/his.14217.","journal-title":"Histopathology"},{"issue":"3","key":"1252_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-019-01960-x","volume":"137","author":"JC Lee","year":"2019","unstructured":"Lee JC, Villanueva-Meyer JE, Ferris SP, Sloan EA, Hofmann JW, Hattab EM, et al. Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1. Acta Neuropathol. 2019;137(3):521\u20135. https:\/\/doi.org\/10.1007\/s00401-019-01960-x.","journal-title":"Acta Neuropathol"},{"issue":"14","key":"1252_CR12","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"1252_CR13","unstructured":"BD VdAGOC. Genomics in the cloud: using Docker, GATK, and WDL in Terra. 1st ed. Sebastopol: O\u2019Reilly Media; 2020."},{"issue":"1","key":"1252_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357. https:\/\/doi.org\/10.1038\/nprot.2008.211.","journal-title":"Nat Protoc"},{"issue":"8","key":"1252_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.21037\/atm-21-1317","volume":"9","author":"Z Li","year":"2021","unstructured":"Li Z, Jin Y, Zou Q, Shi X, Wu Q, Lin Z, et al. Integrated genomic and transcriptomic analysis suggests KRT18 mutation and MTAP are key genetic alterations related to the prognosis between astrocytoma and glioblastoma. Ann Transl Med. 2021;9(8):713. https:\/\/doi.org\/10.21037\/atm-21-1317.","journal-title":"Ann Transl Med"},{"issue":"12","key":"1252_CR16","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/bjc.2017.354","volume":"117","author":"C Dantas-Barbosa","year":"2017","unstructured":"Dantas-Barbosa C, Lesluyes T, Loarer FL, Chibon F, Treilleux I, Coindre JM, et al. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma. Br J Cancer. 2017;117(12):1787\u201397. https:\/\/doi.org\/10.1038\/bjc.2017.354.","journal-title":"Br J Cancer"},{"issue":"3","key":"1252_CR17","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbrc.2013.05.019","volume":"435","author":"J Han","year":"2013","unstructured":"Han J, Tian R, Yong B, Luo C, Tan P, Shen J, et al. Gas6\/Axl mediates tumor cell apoptosis, migration and invasion and predicts the clinical outcome of osteosarcoma patients. Biochem Biophys Res Commun. 2013;435(3):493\u2013500. https:\/\/doi.org\/10.1016\/j.bbrc.2013.05.019.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1252_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.celrep.2016.10.001","volume":"17","author":"V Kedage","year":"2016","unstructured":"Kedage V, Selvaraj N, Nicholas TR, Budka JA, Plotnik JP, Jerde TJ, et al. An interaction with ewing\u2019s sarcoma breakpoint protein EWS defines a specific oncogenic mechanism of ETS factors rearranged in prostate cancer. Cell Rep. 2016;17(5):1289\u2013301. https:\/\/doi.org\/10.1016\/j.celrep.2016.10.001.","journal-title":"Cell Rep"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01252-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01252-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01252-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:07:50Z","timestamp":1664014070000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01252-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01252-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"16 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted in accordance with the Declaration of Helsinki and under the guidelines of the institutional board on ethics of the Sanbo Brain Hospital, Capital Medical University, Beijing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}